| Literature DB >> 26812963 |
Mary M Cameron1, Alvaro Acosta-Serrano2, Caryn Bern3, Marleen Boelaert4, Margriet den Boer5, Sakib Burza6, Lloyd A C Chapman7, Alexandra Chaskopoulou8, Michael Coleman9, Orin Courtenay10, Simon Croft11, Pradeep Das12, Erin Dilger13, Geraldine Foster14, Rajesh Garlapati15, Lee Haines16, Angela Harris17, Janet Hemingway18, T Déirdre Hollingsworth19, Sarah Jervis20, Graham Medley21, Michael Miles22, Mark Paine23, Albert Picado24, Richard Poché25, Paul Ready26, Matthew Rogers27, Mark Rowland28, Shyam Sundar29, Sake J de Vlas30, David Weetman31.
Abstract
Visceral Leishmaniasis (VL) is a neglected vector-borne disease. In India, it is transmitted to humans by Leishmania donovani-infected Phlebotomus argentipes sand flies. In 2005, VL was targeted for elimination by the governments of India, Nepal and Bangladesh by 2015. The elimination strategy consists of rapid case detection, treatment of VL cases and vector control using indoor residual spraying (IRS). However, to achieve sustained elimination of VL, an appropriate post elimination surveillance programme should be designed, and crucial knowledge gaps in vector bionomics, human infection and transmission need to be addressed. This review examines the outstanding knowledge gaps, specifically in the context of Bihar State, India.The knowledge gaps in vector bionomics that will be of immediate benefit to current control operations include better estimates of human biting rates and natural infection rates of P. argentipes, with L. donovani, and how these vary spatially, temporally and in response to IRS. The relative importance of indoor and outdoor transmission, and how P. argentipes disperse, are also unknown. With respect to human transmission it is important to use a range of diagnostic tools to distinguish individuals in endemic communities into those who: 1) are to going to progress to clinical VL, 2) are immune/refractory to infection and 3) have had past exposure to sand flies.It is crucial to keep in mind that close to elimination, and post-elimination, VL cases will become infrequent, so it is vital to define what the surveillance programme should target and how it should be designed to prevent resurgence. Therefore, a better understanding of the transmission dynamics of VL, in particular of how rates of infection in humans and sand flies vary as functions of each other, is required to guide VL elimination efforts and ensure sustained elimination in the Indian subcontinent. By collecting contemporary entomological and human data in the same geographical locations, more precise epidemiological models can be produced. The suite of data collected can also be used to inform the national programme if supplementary vector control tools, in addition to IRS, are required to address the issues of people sleeping outside.Entities:
Mesh:
Year: 2016 PMID: 26812963 PMCID: PMC4729074 DOI: 10.1186/s13071-016-1309-8
Source DB: PubMed Journal: Parasit Vectors ISSN: 1756-3305 Impact factor: 3.876
Research questions relating to sand fly population dynamics and behaviour to inform surveillance and improve control of P. argentipes in Bihar
| • What are the blood-feeding preferences of | |
| • Do natural infection rates of | |
| • How far does | |
| • What is the EIR for | |
| • What is the relative importance of indoor and outdoor transmission in relation to IRS? | |
| • Is IRS selecting for resistance and, if so, what are the mechanisms and at what rate is it emerging in the field? | |
| • If IRS as the stand-alone vector control tool does not stop transmission, what are the appropriate available tools to control residual transmission? |
Research questions to address human infection and transmission to validate and optimize existing prototype markers for detection of past exposure, putatively highly infectious individuals and progressors to active VL
| • What is the value of new prototype point of care (POC) tests (IgG1 RDT; urinary antigen detection) in comparison with existing quantitative antibody tests (and qPCR) to detect those healthy but infected individuals who are likely to progress to clinical VL (progressors)? | |
| • What is the value of IGRA as an alternative to LST (which is not currently allowed for use in India) for documenting the presence of cellular immunity (exposed but not susceptible) at population level? | |
| • What is the validity of sand fly saliva antibody detection for detecting past exposure? | |
| • Are progressors to VL a significant source of infection to sand flies as compared to non-progressors? |
Research questions to address knowledge gaps in VL transmission to optimise control strategies and ensure sustained elimination
| • What are the spatial and temporal patterns of VL transmission, and how spatially heterogeneous are they? | |
| • Are VL cases a good indicator for infection prevalence? | |
| • How big is the pool of asymptomatics and how much do they contribute to transmission? | |
| • What is the optimal response strategy to new cases, e.g. in what radius around new cases should vector control be performed and for how long? | |
| • What is the right surveillance strategy to ensure sustained elimination? What markers should be used and which age groups should be tested? |